These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
482 related articles for article (PubMed ID: 11362832)
1. Update on HIV protease inhibitors. Vella S AIDS Clin Care; 1995 Oct; 7(10):79-82, 88. PubMed ID: 11362832 [TBL] [Abstract][Full Text] [Related]
2. Conference looks at HIV drug resistance. Chang HE GMHC Treat Issues; 1995 Sep; 9(9):6-8. PubMed ID: 11362910 [TBL] [Abstract][Full Text] [Related]
3. Protease inhibitors and prevention of cross resistance. Levin J AIDS Treat News; 1995 Oct; (no 232):1-3. PubMed ID: 11362875 [TBL] [Abstract][Full Text] [Related]
4. Protease inhibitors shine in triple combinations. AIDS Alert; 1996 Mar; 11(3):31-2. PubMed ID: 11363243 [TBL] [Abstract][Full Text] [Related]
5. Nipping HIV in the bud. Smart T GMHC Treat Issues; 1996 Aug; 10(8):3-6. PubMed ID: 11363719 [TBL] [Abstract][Full Text] [Related]
6. New drugs for HIV infection. Med Lett Drugs Ther; 1996 Apr; 38(972):35-7. PubMed ID: 8606677 [TBL] [Abstract][Full Text] [Related]
7. Ritonavir: first to prolong survival. MacDougall DS J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):38-44. PubMed ID: 11363517 [TBL] [Abstract][Full Text] [Related]
8. No tease this time--pros and cons of a long-awaited anti-HIV drug. Chang HE Posit Aware; 1996; 7(1):18-20. PubMed ID: 11363118 [TBL] [Abstract][Full Text] [Related]
9. Merck protease inhibitor: more news from Retroviruses Conference. James JS AIDS Treat News; 1996 Feb; (no 241):1-3. PubMed ID: 11363186 [TBL] [Abstract][Full Text] [Related]
10. [Which is the strategy? The latest in the use of antiretrovirals]. Agosto M Sidahora; 1995; ():33-4. PubMed ID: 11363205 [TBL] [Abstract][Full Text] [Related]
11. Protease inhibitor trials moving to next phase. AIDS Alert; 1995 Aug; 10(8):100-1. PubMed ID: 11362675 [TBL] [Abstract][Full Text] [Related]
12. Potent new AIDS drugs underscore promise of combination therapy. AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225 [TBL] [Abstract][Full Text] [Related]
14. The choice of HIV protease inhibitor: indinavir is currently the best option. Prescrire Int; 1999 Apr; 8(40):55-60. PubMed ID: 10848067 [TBL] [Abstract][Full Text] [Related]
15. Freedom of choice. Vazquez E Posit Aware; 1996; 7(3):9, 19. PubMed ID: 11363432 [TBL] [Abstract][Full Text] [Related]
16. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. Collier AC; Coombs RW; Schoenfeld DA; Bassett RL; Timpone J; Baruch A; Jones M; Facey K; Whitacre C; McAuliffe VJ; Friedman HM; Merigan TC; Reichman RC; Hooper C; Corey L N Engl J Med; 1996 Apr; 334(16):1011-7. PubMed ID: 8598838 [TBL] [Abstract][Full Text] [Related]